Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab). Juyong Hong, Yuhwa Lee,Changsoo Lee, Suhyeon Eo,Soyeon Kim,Nayoung Lee, Jongmin Park,Seungkyu Park, Donghyuck Seo,Min Jeong, Youngji Lee, Soojeong Yeon,George Bou-Assaf,Zoran Sosic,Wei Zhang,Orlando JaquezMABS(2017)引用 68|浏览6暂无评分关键词Biosimilar,critical quality attribute,flixabi,infliximab,renflexis,SB2AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要